CSTL
Castle Biosciences, Inc. (CSTL)
NASDAQ · Healthcare
Castle Biosciences, Inc. annual/quarterly total liabilities history from 2018 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Castle Biosciences, Inc. total liabilities for the quarter ending December 31, 2025 were 107.7M, a 42.82% increase year-over-year.
- Castle Biosciences, Inc. total liabilities for 2025 were 107.7M, a 42.82% increase from 2024.
- Castle Biosciences, Inc. total liabilities for 2024 were 75.4M, a 21.47% increase from 2023.
- Castle Biosciences, Inc. total liabilities for 2023 were 62.1M, a 28.83% increase from 2022.
- Castle Biosciences, Inc. total liabilities for 2022 were 48.2M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Castle Biosciences, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $108 |
| 2024 | $75 |
| 2023 | $62 |
| 2022 | $48 |
| 2021 | $51 |
| 2020 | $24 |
| 2019 | $35 |
| 2018 | $32 |
| Castle Biosciences, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $108 |
| 2024-12-31 | $75 |
| 2023-12-31 | $62 |
| 2022-12-31 | $48 |
| 2021-12-31 | $51 |
| 2020-12-31 | $24 |
| 2019-12-31 | $35 |
| 2018-12-31 | $32 |
Castle Biosciences, Inc. Total Liabilities — FAQ
Castle Biosciences, Inc. (CSTL) total liabilities over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CSTL's total liabilities history?
The chart and table above show Castle Biosciences, Inc.'s total liabilities by year and by quarter, including the growth rate.